Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC) Read more
Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response Read more
Environmental Sensor Market to Cross $4.38 Billion by 2034 at CAGR of 7.7%, by Stringent Environmental Regulations -Latest Industry Research by The Insight Partners Read more
Thermal Imaging Market to Reach $8.78 Billion by 2034 at 7.2% GAGR, Fuelled by Rise in Military Expenditure-Latest Industry Research by The Insight Partners Read more